Why Practicing Strategic Patience is Critical for Medtech Entrepreneurs

Interview with Dr. Tej Singh, Founder of Fist Assist Devices

Over the last 20 years, Dr. Tej Singh has served as the Founder and Chief of Vascular Surgery for three large, multidisciplinary vascular programs in Silicon Valley. He has vast experience with renal failure and vascular access procedures, and is acutely focused on his first company, Fist Assist Devices. Dr. Singh’s company is developing the first renal care wearable device for venous enlargement and dialysis enhancement.

In this episode, Dr. Singh and I talk about the primary challenge that Fist Assist Devices is trying to solve, the origin story for their first product, his approach to mapping out clinical trial strategies, and much more.

Interview Highlights with Dr. Tej Singh

  • Who is Dr. Tej Singh and what is his background?

  • What is Fist Assist Devices and what challenges are they trying to solve?

  • The origin story for their first product and the critical inflection points for the company.

  • How Dr. Singh evaluated the IP landscape for his first device.

  • Dr. Singh’s approach to mapping out clinical trial strategies.

  • How he navigated the insurance coverage and reimbursement landscape.

  • His unique approach to strategic patience and why it’s crucial for medtech startups.

  • Dr. Singh’s favorite book, the leader he most admires, and the advice he’d give to his 30-year-old self.

Premium Members Only

Premium Members Only

You don't have access to this post, but if you become a premium member, you'll be able to see the whole thing, including many other exclusive benefits.

You don't have access to this post, but if you become a premium member, you'll be able to see the whole thing, including many other exclusive benefits.

You May Like These Articles

Medsider Premium

Become a premium member and unlock access to exclusive Medsider benefits.

Medsider Mentors

Medsider Mentors

Medsider Playbooks

Medsider Playbooks

Playbook

A Guide to Widespread Adoption in Medtech

In medtech, developing novel, impactful technology is often just the starting line. The real race begins when you try to integrate your solution into the often-resistant healthcare system – a hurdle that has tripped up countless promising companies. Here are the key strategies and lessons from five veterans in the medtech space on how to overcome this hurdle.

Copyright © Medsider 2024 • All rights reserved.

Subscribe

Sign In

Suggest a Guest

Copyright © Medsider 2024 • All rights reserved.

Subscribe

Sign In

Suggest a Guest

Copyright © Medsider 2024 • All rights reserved.

Subscribe

Sign In

Suggest a Guest